BackTarsus Pharmaceuticals Overview
Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Target Price

Where could TARS trade next? Consensus target price: $100.

Get informed when a big investor buys or sells

+ Follow

Share Price

$80.28

Average Target Price

$103.4328.8% upside

7 analysts in the last 4 months

High: $116 | Low: $89

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-11-04H.C. WainwrightMatt Caufield$10632% upsideOpen
2026-09-24Goldman SachsAndrea Newkirk$11644.5% upsideOpen
2026-09-16Barclays$11037% upsideOpen
2026-09-08Jefferies$10530.8% upsideOpen
2026-08-12OppenheimerMazahir Alimohamed$10024.6% upsideOpen
2026-08-03Mizuho Securities$9822.1% upsideOpen
2026-07-21GuggenheimEddie Hickman$8910.9% upsideOpen
2026-02-05Goldman Sachs$6815.3% downsideOpen
2025-12-08Barclays$10024.6% upsideOpen
2025-11-20Mizuho Securities$10024.6% upsideOpen
2025-11-06Goldman SachsAndrea Tan$5136.5% downsideOpen
2025-10-20H.C. Wainwright$889.6% upsideOpen
2025-05-02GuggenheimEddie Hickman$844.6% upsideOpen
2025-03-06Jefferies$5827.8% downsideOpen
2025-01-27BarclaysBalaji Prasad$6222.8% downsideOpen
2025-01-22OppenheimerFrancois Brisebois$7210.3% downsideOpen
2024-09-23OppenheimerFrancois Brisebois$6321.5% downsideOpen
2024-05-13H.C. WainwrightOren Livnat$6124% downsideOpen

Tarsus Pharmaceuticals (TARS) FAQ

Tarsus Pharmaceuticals posts a target price of $100. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $100 for TARS means covering analysts, on average, see the stock 28.8% upside of $80.28 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for TARS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Tarsus Pharmaceuticals's other metric pages and overview cover the third.

Judging Tarsus Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $100 here, then scan peer and history charts to see if the gap is persistent.